文献速递腹部技术与安全CT

双层双能CT重复检查中无癌患者腹部正常实质影像组学特征的稳健性

Robustness of radiomic features in healthy abdominal parenchyma of patients with repeated examinations on dual-layer dual-energy CT.
PubMed 文献 · Eur J Radiol · 2024-03-26

回顾性纳入160例无可见肿瘤负担患者共480次腹部门静脉期双层双能CT重复检查,评估肝、腰大肌、胰头、脾正常实质影像组学特征的稳健性;仅4.58%(25/546)特征稳健,一阶特征稳健比例最高(20.37%,22/108),重建视野、管电流和感兴趣区大小为稳健性决定因素。

要点

  • 重复检查中正常腹部实质仅4.58%影像组学特征稳健,一阶特征稳健率最高20.37%。
  • 重建视野和X射线管电流是所有器官特征稳健性的显著决定因素(p<0.001)。
  • 感兴趣区大小除胰头(p=0.135)外,对其余器官稳健性均有显著影响(p<0.001)。

核心结论

  • 在协议和CT扫描仪一致的条件下,无癌受试者重复检查所获影像组学特征稳健性有限,一阶特征稳健比例最高。

研究设计与样本

  • 单中心、经IRB批准的回顾性研究,纳入2016年5月至2020年1月至少两次腹部门静脉期双能CT检查的无可见肿瘤负担患者160例,共480次重复检查(每人2-4次),由两名委员会认证放射科医生(分别4年和5年经验)在肝(3段和6段)、腰大肌(左右)、胰头和脾放置并校对圆形感兴趣区,使用PyRadiomics提取特征。

关键影像表现/征象

  • 在肝、腰大肌、胰头和脾正常表现实质内放置圆形感兴趣区提取影像组学特征。
  • 所有器官和特征类别中仅4.58%(25/546)特征稳健,一阶特征类别稳健率最高为20.37%(22/108)。
  • 灰度共生矩阵、灰度依赖矩阵、灰度游程长度矩阵、灰度大小区域矩阵和邻域灰度差矩阵类别稳健特征比例低,范围为0.00%-1.19%。

诊断标准与关键数值

  • 采用一致性相关系数检验影像组学特征稳健性,阈值0.75视为特征稳健。

临床应用与阅片要点

  • 亚组分析显示重建视野和X射线管电流是所有器官特征稳健性的决定因素(各器官亚组差异显著,p<0.001)。
  • 感兴趣区大小对胰头特征稳健性无显著差异(p=0.135),对其余所有器官有显著差异(p<0.001)。

局限性

  • 本文为单中心、回顾性研究。
  • 仅4.58%(25/546)特征稳健,一阶特征稳健比例最高也仅20.37%(22/108),其他类别稳健比例范围为0.00%-1.19%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Robustness of radiomic features in physiological tissue is an important prerequisite for quantitative analysis of tumor biology and response assessment. In contrast to previous studies which focused on different tumors with mostly short scan-re-scan intervals, this study aimed to evaluate the robustness of radiomic features in cancer-free patients and over a clinically encountered inter-scan interval.

MATERIALS AND METHODS: Patients without visible tumor burden who underwent at least two portal-venous phase dual energy CT examinations of the abdomen between May 2016 and January 2020 were included, while macroscopic tumor burden was excluded based upon follow-up imaging for all patients (≥3 months). Further, patients were excluded if no follow-up imaging was available, or if the CT protocol showed deviations between repeated examinations. Circular regions of interest were placed and proofread by two board-certified radiologists (4 years and 5 years experience) within the liver (segments 3 and 6), the psoas muscle (left and right), the pancreatic head, and the spleen to obtain radiomic features from normal-appearing organ parenchyma using PyRadiomics. Radiomic feature robustness was tested using the concordance correlation coefficient with a threshold of 0.75 considered indicative for deeming a feature robust.

RESULTS: In total, 160 patients with 480 repeated abdominal CT examinations (range: 2-4 per patient) were retrospectively included in this single-center, IRB-approved study. Considering all organs and feature categories, only 4.58 % (25/546) of all features were robust with the highest rate being found in the first order feature category (20.37 %, 22/108). Other feature categories (grey level co-occurrence matrix, grey level dependence matrix, grey level run length matrix, grey level size zone matrix, and neighborhood gray-tone difference matrix) yielded an overall low percentage of robust features (range: 0.00 %-1.19 %). A subgroup analysis revealed the reconstructed field of view and the X-ray tube current as determinants of feature robustness (significant differences in subgroups for all organs, p < 0.001) as well as the size of the region of interest (no significant difference for the pancreatic head with p = 0.135, significant difference with p < 0.001 for all other organs).

CONCLUSION: Radiomic feature robustness obtained from cancer-free subjects with repeated examinations using a consistent protocol and CT scanner was limited, with first order features yielding the highest proportion of robust features.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Schöneck M, Lennartz S, Zopfs D, et al. Robustness of radiomic features in healthy abdominal parenchyma of patients with repeated examinations on dual-layer dual-energy CT. Eur J Radiol. 2024. PMID: 38677039. doi:10.1016/j.ejrad.2024.111447

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。